Cargando…

Vaccination frequency in people newly diagnosed with multiple sclerosis

BACKGROUND: Infections are discussed as risk factor for multiple sclerosis (MS) development and relapses. This may lead to decreased vaccination frequency in newly diagnosed patients. OBJECTIVE: The aim of this study was to evaluate the relation of MS diagnosis to subsequent vaccination frequency. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Darvishi, Sonia, Donnachie, Ewan, Gasperi, Christiane, Hapfelmeier, Alexander, Hemmer, Bernhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687801/ https://www.ncbi.nlm.nih.gov/pubmed/37830337 http://dx.doi.org/10.1177/13524585231199084

Ejemplares similares

Association of pregnancies with risk of multiple sclerosis
por: Gasperi, Christiane, et al.
Publicado: (2022)

A Systematic Assessment of Prevalence, Incidence and Regional Distribution of Multiple Sclerosis in Bavaria From 2006 to 2015
por: Daltrozzo, Tanja, et al.
Publicado: (2018)

Gray matter atrophy in relapsing-remitting multiple sclerosis is associated with white matter lesions in connecting fibers
por: Bussas, Matthias, et al.
Publicado: (2021)

Association of the retinal vasculature, intrathecal immunity, and disability in multiple sclerosis
por: Noll, Christina, et al.
Publicado: (2022)

Is serum vitamin D levels associated with disability in patients with newly diagnosed multiple sclerosis?
por: Hatamian, Hamidreza, et al.
Publicado: (2013)

Retrospective cohort study to devise a treatment decision score predicting adverse 24-month radiological activity in early multiple sclerosis
por: Hapfelmeier, Alexander, et al.
Publicado: (2023)

Activated monocytes and markers of inflammation in newly diagnosed multiple sclerosis
por: Carstensen, Mikkel, et al.
Publicado: (2020)

CSF parameters associated with early MRI activity in patients with MS
por: Klein, Ana, et al.
Publicado: (2019)

Lesion location across diagnostic regions in multiple sclerosis
por: Pongratz, Viola, et al.
Publicado: (2023)

SARS-CoV-2 infection and cardiovascular or pulmonary complications in ambulatory care: A risk assessment based on routine data
por: Karapetyan, Siranush, et al.
Publicado: (2021)

Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis
por: D’Amico, Emanuele, et al.
Publicado: (2022)

Treatment Courses of Patients Newly Diagnosed with Multiple Sclerosis in 2012–2018
por: Sipilä, Jussi O. T.
Publicado: (2023)

Update on immunopathogenesis and immunotherapy in multiple sclerosis
por: Selter, Rebecca C, et al.
Publicado: (2013)

Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing–remitting multiple sclerosis (RRMS)
por: Gold, Ralf, et al.
Publicado: (2015)

Newly Diagnosed Amyotrophic Lateral Sclerosis in a Patient with Multiple-System Atrophy
por: Choi, Moonkyung, et al.
Publicado: (2020)

MRI-derived g-ratio and lesion severity in newly diagnosed multiple sclerosis
por: York, Elizabeth N, et al.
Publicado: (2021)

Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey
por: Portaccio, Emilio, et al.
Publicado: (2021)

New immunopathologic insights into multiple sclerosis
por: Hemmer, Bernhard, et al.
Publicado: (2003)

Vaccine hesitancy in people with multiple sclerosis
por: Lechner-Scott, Jeannette S, et al.
Publicado: (2022)

Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States
por: Kern, David M., et al.
Publicado: (2020)

Newly Diagnosed Multiple Sclerosis Presenting as Brown-Séquard Syndrome: A Case Report
por: Hoebee, Shelby, et al.
Publicado: (2022)

Serum heat shock protein 70 levels as a biomarker for inflammatory processes in multiple sclerosis
por: Lechner, Patricia, et al.
Publicado: (2018)

Incidence of post-COVID syndrome and associated symptoms in outpatient care in Bavaria, Germany: a retrospective cohort study using routinely collected claims data
por: Donnachie, Ewan, et al.
Publicado: (2022)

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
por: Castrop, Florian, et al.
Publicado: (2013)

Prediction of Multiple sclerosis disease using machine learning classifiers: a comparative study
por: DARVISHI, SONIA, et al.
Publicado: (2021)

Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis
por: Stilund, Morten, et al.
Publicado: (2014)

Newly diagnosed multiple sclerosis in a patient with ocular myasthenia gravis: A case report
por: Bong, Jeong Bin, et al.
Publicado: (2022)

Body fat composition as predictive factor for treatment response in patients with newly diagnosed multiple myeloma – subgroup analysis of the prospective GMMG MM5 trial
por: GroΔ, Jonathan P., et al.
Publicado: (2017)

Vaccine hesitancy among people with multiple sclerosis
por: Yap, Siew Mei, et al.
Publicado: (2021)

ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
por: Otero-Romero, Susana, et al.
Publicado: (2023)

Incidence of depression in people with newly diagnosed tuberculosis in Ethiopia: a cohort study
por: Ambaw, Fentie, et al.
Publicado: (2020)

Development and usability testing of a patient decision aid for newly diagnosed relapsing multiple sclerosis patients
por: Bansback, Nick, et al.
Publicado: (2019)

Cortical Thickness and Serum NfL Explain Cognitive Dysfunction in Newly Diagnosed Patients With Multiple Sclerosis
por: Cruz-Gomez, Álvaro J., et al.
Publicado: (2021)

Association of cerebrospinal inflammatory profile with radiological features in newly diagnosed treatment-naïve patients with multiple sclerosis
por: Ashida, Shinji, et al.
Publicado: (2022)

All-Cause Health Care Utilization and Costs Associated with Newly Diagnosed Multiple Sclerosis in the United States
por: Asche, Carl V., et al.
Publicado: (2010)

Frequency and Prognosis of Pulmonary Metastases in Newly Diagnosed Gastric Cancer
por: Sun, Zepang, et al.
Publicado: (2019)

Frequency and Risk Factors for Metastasis in Newly Diagnosed Appendiceal Carcinoma
por: Minhas, Ahmed, et al.
Publicado: (2021)

Cost-of-Illness Progression Before and After Diagnosis of Multiple Sclerosis: A Nationwide Register-Based Cohort Study in Sweden of People Newly Diagnosed with Multiple Sclerosis and a Population-Based Matched Reference Group
por: Murley, Chantelle, et al.
Publicado: (2021)

Oprozomib in patients with newly diagnosed multiple myeloma
por: Hari, Parameswaran, et al.
Publicado: (2019)

Daratumumab in untreated newly diagnosed multiple myeloma
por: Abdallah, Nadine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ia16p057hc5tjf9upg27vuljp6